Alerts will be sent to your verified email
Verify Email
BPLPHARMA
|
Bharat Parenterals
|
Sakar Healthcare
|
Prevest Denpro
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
R&D as a % of Total Sales
|
0.41 % | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
12.73 % | 9.28 % | 23.02 % |
|
5yr average Equity Multiplier
|
1.76 | 1.75 | 1.16 |
|
5yr Average Asset Turnover Ratio
|
0.86 | 0.5 | 0.69 |
|
5yr Avg Net Profit Margin
|
8.73 % | 10.38 % | 28.95 % |
|
Price to Book
|
2.29 | 2.37 | 6.31 |
|
P/E
|
0.0 | 42.98 | 34.03 |
|
5yr Avg Cash Conversion Cycle
|
122.06 Days | -14.29 Days | 57.55 Days |
|
Inventory Days
|
46.56 Days | 46.75 Days | 26.01 Days |
|
Days Receivable
|
179.99 Days | 51.16 Days | 50.74 Days |
|
Days Payable
|
95.97 Days | 103.34 Days | 75.73 Days |
|
5yr Average Interest Coverage Ratio
|
22.68 | 5.43 | 75.33 |
|
5yr Avg ROCE
|
16.02 % | 10.08 % | 30.18 % |
|
5yr Avg Operating Profit Margin
|
11.16 % | 24.06 % | 36.73 % |
|
5 yr average Debt to Equity
|
0.26 | 0.47 | 0.02 |
|
5yr CAGR Net Profit
|
-9.67 % | 3.94 % | 17.49 % |
|
5yr Average Return on Assets
|
8.0 % | 5.37 % | 19.63 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
67.2 % | 53.58 % | 73.6 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-6.64 % | -13.96 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Bharat Parenterals
|
Sakar Healthcare
|
Prevest Denpro
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|